New Drug Approvals

Home | Pages | Archives

Quad Pill for HIV Appears Safe in Renal Disease

July 8, 2013 3:24 am


Published: Jul 7, 2013

 

By Ed Susman, Contributing Writer, MedPage Today
Reviewed by Zalman S. Agus, MD; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania
 Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.

 KUALA LUMPUR — HIV patients with mild to moderate renal impairment appear to tolerate treatment with a combination tablet that contains drugs known to impact kidney function, a phase III, open-label, two-cohort study found.

The treatment group receiving the four-drug combination of elvitegravir, cobicistat, tenofovir DF, and emtricitabine, branded as Stribild

http://www.medpagetoday.com/MeetingCoverage/IAS/40282

Share this:

Posted by DR ANTHONY MELVIN CRASTO Ph.D

Categories: Uncategorized

Tags: , , , , , , , , , , , , , , , , , , , , ,

6 Responses to “Quad Pill for HIV Appears Safe in Renal Disease”

  1. Reblogged this on MedChemHot.Pakistan.

    Like

    By suraiyahaider on July 8, 2013 at 2:44 pm

  2. Reblogged this on MariaGairos–DRUGS.

    Like

    By mariagairos on July 8, 2013 at 2:54 pm

  3. Reblogged this on Srilanka-Chem.

    Like

    By srilankachem on July 8, 2013 at 2:58 pm

  4. Reblogged this on Srilanka-Chem.

    Like

    By srilankachem on July 8, 2013 at 2:59 pm

  5. Reblogged this on GREEN MED CHEMISTRY.

    Like

    By sarakinsley on July 9, 2013 at 8:09 am

  6. Reblogged this on Med.Chem.in.Iceland.

    Like

    By lindaedwards689 on July 10, 2013 at 10:56 am

Leave a Reply

Mobile Site | Full Site

Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.